Sodium Valproate-induced Adult-onset Type 2 Citrullinemia

Sodium Valproate-induced Adult-onset Type 2 Citrullinemia

Bibliographic Details
Main Authors:	Başak Elçin Ateş, Turgay Demir, Deniz Kor, Remzi Emre Şahin, Şebnem Bıçakçı
Format:	Article
Language:	English
Published:	Galenos Yayinevi 2022-09-01
Series:	Türk Nöroloji Dergisi
Subjects:	adult-onset encephalopathy sodium valproate type 2 citrullinemia urea cycle defects
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjn&un=TJN-37539

Similar Items

Hyperammonemia in a pregnant woman with citrullinemia type I: a case report and literature review
by: Yimeng Zhou, et al.
Published: (2022-12-01)

The menacing side of valproate: A case series of valproate-induced hyperammonemia
by: Deeksha Elwadhi, et al.
Published: (2017-01-01)

Gene Therapy in Combination with Nitrogen Scavenger Pretreatment Corrects Biochemical and Behavioral Abnormalities of Infant Citrullinemia Type 1 Mice
by: Andrea Bazo, et al.
Published: (2022-11-01)

Valproate-induced Hyperammonemic Encephalopathy
by: Hsiao-Feng Chou, et al.
Published: (2008-10-01)

Adult onset episodic encephalopathy due to citrin deficiency—A case report
by: Dipti Baskar, et al.
Published: (2023-01-01)

Electroencephalography and transcranial Doppler ultrasonography in neonatal citrullinemia
by: Pen-Hua Su, et al.
Published: (2014-11-01)

Pseudodendritic keratitis in citrullinemia; a report of an unusual and novel ocular finding in this metabolic disorder
by: Davoud Amirkashani, et al.
Published: (2024-06-01)

Targeted breast milk modification: A low-cost feeding option in young infants with citrullinemia
by: Saikat Patra, et al.
Published: (2021-01-01)

Valproate, risperidone, and paliperidone: A case of valproate-induced hyperammonemic encephalopathy
by: Kyle Wesselman, PharmD candidate, MA, BS, et al.
Published: (2024-02-01)

Citrullinemia type I and hypertrophic pyloric stenosis in a 1-month old male infant
by: Yoona Rhee, et al.
Published: (2013-01-01)

Functional identification of two novel variants and a hypomorphic variant in ASS1 from patients with Citrullinemia type I
by: Jing Liu, et al.
Published: (2023-07-01)

Valproate-induced hyperammonemic encephalopathy. A case report
by: A. Cerame, et al.
Published: (2022-06-01)

ASS1 gene mutation in a neonate with citrullinemia type Ⅰ
by: LYU Ya-nan, SONG Dong-po, WANG Wei-qing, CHEN Yan-ping
Published: (2020-10-01)

Valproate-induced hyperammonemic encephalopathy enhanced by topiramate and phenobarbitone: A case report and an update
by: Vivekanandan S, et al.
Published: (2010-01-01)

Identification of Novel Mutations in Chinese Infants With Citrullinemia
by: Zhi Cheng, et al.
Published: (2022-03-01)

A Case Series of Severe Hyperammonemia Encephalopathy Related to Valproate: Can Antipsychotics Increase the Risk?
by: Effat Davoudi-Monfared, et al.
Published: (2019-07-01)

Valproate induced encephalopathy: Paradigm of normal ammonia levels
by: P. Barbosa, et al.
Published: (2021-04-01)

Valproate induced hyperammonemic encephalopathy: a rare adverse effect of a common drug
by: Sanaullah Mudassir, et al.
Published: (2023-12-01)

Valproate-induced hyperammonemia - uncovering an underlying inherited metabolic disorder: a case report
by: Shaine Mehta, et al.
Published: (2018-05-01)

What are the effects of taking 300 pills of sodium valproate? - case report
by: Kinga Pożarowska, et al.
Published: (2022-08-01)

Analysis of ASS1 gene in ten unrelated middle eastern families with citrullinemia type 1 identifies rare and novel variants
by: Melissa Daou, et al.
Published: (2023-02-01)

Type 1 citrullinemia patient with Brugada pattern undergoing general anesthesia for dental extractions: A case report
by: Fabio Dell’Olio, et al.
Published: (2023-08-01)

Sodium valproate induced hyperammonaemia in an elderly patient with affective disorder
by: Kumanan Thirunavukarasu, et al.
Published: (2011-06-01)

Sodium Valproate as an Adjunctive to Risperidone in Treatment of Schizophrenia
by: V Omrani Fard, et al.
Published: (2007-01-01)

Ammoniagenic Action of Valproate without Signs of Hepatic Dysfunction in Rats: Possible Causes and Supporting Evidence
by: Gubidat Alilova, et al.
Published: (2024-03-01)

Use of carglumic acid in valproate‐induced hyperammonemia: 25 pediatric cases
by: Laura María Palomino Pérez, et al.
Published: (2020-09-01)

Reversible Valproate-Induced Subacute Encephalopathy Associated With a MT-ATP8 Variant in the Mitochondrial Genome
by: Giovanna De Michele, et al.
Published: (2018-08-01)

MIGRAINE HEADACHE MANAGEMENT: PROPRANOLOL VERSUS SODIUM VALPROATE
by: H CHITSAZ, et al.
Published: (2002-03-01)

Food Preferences of Patients with Citrin Deficiency
by: Miki Okamoto, et al.
Published: (2021-09-01)

Valproate-induced hypothyroidism in schizoaffective disorder
by: J. Facucho-Oliveira, et al.
Published: (2022-06-01)

Valproate in pregnancy: comment from the SAPP
by: Irene Hösli, et al.
Published: (2021-02-01)

Medium-chain triglyceride supplementation under a low-carbohydrate formula is a promising therapy for adult-onset type II citrullinemia
by: Kiyoshi Hayasaka, et al.
Published: (2014-01-01)

Comparative study of magnesium, sodium valproate, and concurrent magnesium-sodium valproate therapy in the prevention of migraine headaches: a randomized controlled double-blind trial
by: Samira Khani, et al.
Published: (2021-04-01)

Effect of levetiracetam and valproate on late-onset post-traumatic seizures
by: Yanli Wang, et al.
Published: (2023-04-01)

Sodium Valproate Exacerbating an Underlying Disorder of Fatty Acid Metabolism
by: Jamie Bellinge, et al.
Published: (2016-09-01)

Citrullinemia type I is associated with a novel splicing variant, c.773 + 4A > C, in ASS1: a case report and literature review
by: Yiming Lin, et al.
Published: (2019-06-01)

Clinical, laboratory data and outcomes of 17 Iranian citrullinemia type 1 patients: Identification of five novel ASS1 gene mutations
by: Shirin Moarefian, et al.
Published: (2022-05-01)

Effectiveness of Vitamin B2 versus Sodium Valproate in Migraine Prophylaxis: a randomized clinical trial
by: Abolghasem Rahimdel, et al.
Published: (2015-10-01)

Comparision of the Efficacy of Two Combinations;Sodium Valproate with Lithium & Sodium Valproate with Olanzapine in Treatment of Acute Mania
by: S Amanat, et al.
Published: (2005-10-01)

Psychiatric adult-onset of urea cycle disorders: A case-series
by: Adrien Bigot, et al.
Published: (2017-09-01)